» Articles » PMID: 18600325

Profile of Th17 Cytokines (IL-17, TGF-beta, IL-6) and Th1 Cytokine (IFN-gamma) in Patients with Immune Thrombocytopenic Purpura

Overview
Journal Ann Hematol
Specialty Hematology
Date 2008 Jul 5
PMID 18600325
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The data on polarization of the immune system towards T helper 1 (Th1) or T helper 2 (Th2) cells in immune thrombocytopenic purpura (ITP) are limited and contradictory. Th17 characterized by the production of Interleukin 17 (IL-17) has been shown to play a crucial part in the induction of autoimmune diseases. To further investigate the role of Th cytokines in the pathogenesis of ITP, we measured the plasma concentration of three Th17-associated cytokines [IL-17, transforming growth factor-ss (TGF-ss), IL-6] and Th1 cytokine interferon-gamma (IFN-gamma) in ITP patients, and evaluated their clinical relevance. The concentration of IL-17, TGF-ss, IL-6, and IFN-gamma in plasma specimens from 29 adults with chronic ITP and 38 controls was analyzed by enzyme-linked immunosorbent assay method. No significant differences of Th17 cytokines (IL-17, TGF-ss, and IL-6) and Th1 cytokine (IFN-gamma) concentration were observed between patients with active ITP and the control group. And the IFN-gamma/IL-17 ratio representing Th1/Th17 cytokine profile was not significantly different between ITP patients and control, either. However, significantly positive correlation between IL-6 and IFN-gamma in ITP patients was observed (r = 0.48, P = 0.01). Among the ITP patients, Plasma IL-17 levels in male were marginally higher than those in female, while similar for TGF-ss, IL-6 or IFN-gamma. There was a significantly positive correlation between age and IL-6 concentration in ITP patients (r = 0.56, P = 0.0002), while no statistical significance between age and the other three cytokines. No significant correlation between cytokine concentrations and platelets or megakaryocytes number was found in ITP patients. In summary, ITP may not be associated with changes of plasma Th17 and Th1 cytokine concentrations relative to control population.

Citing Articles

Advancements and Future Directions of Dual-Target Chimeric Antigen Receptor T-Cell Therapy in Preclinical and Clinical Studies.

Zhang C, Liu H J Immunol Res. 2025; 2025():5845167.

PMID: 39844819 PMC: 11753851. DOI: 10.1155/jimr/5845167.


High Manganese Content of Lipid NanoMn (LNM) by Microfluidic Technology for Enhancing Anti-Tumor Immunity.

Sun J, Gong J, Gong L, Zhu C, Li-Yang L, Wang J Pharmaceutics. 2024; 16(4).

PMID: 38675217 PMC: 11054818. DOI: 10.3390/pharmaceutics16040556.


Contribution of T helper 17 cells and interleukin-17 to the pathogenesis of primary immune thrombocytopenia in Egyptian children.

Hassan T, Zakaria M, Diaa A, Abdalla A, Ahmed A, Abdelmonem D Eur J Pediatr. 2023; 182(12):5673-5679.

PMID: 37823926 PMC: 10746750. DOI: 10.1007/s00431-023-05242-3.


Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP.

Georgi J, Middeke J, Bornhauser M, Matzdorff A, Trautmann-Grill K Blood Adv. 2023; 7(14):3710-3724.

PMID: 37042947 PMC: 10368779. DOI: 10.1182/bloodadvances.2023009949.


Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma.

Du M, Huang L, Kou H, Li C, Hu Y, Mei H Front Immunol. 2022; 13:898341.

PMID: 35784357 PMC: 9244693. DOI: 10.3389/fimmu.2022.898341.